Literature DB >> 11316945

Vascular biology of the isoprostanes.

J L Cracowski1, P Devillier, T Durand, F Stanke-Labesque, G Bessard.   

Abstract

Isoprostanes are a family of compounds produced from polyunsaturated fatty acids via a free-radical-catalysed mechanism. F(2)-isoprostanes are prostaglandin F(2alpha) isomers derived from arachidonic acid. These compounds induce potent vasoconstriction, mediated primarily by TP receptor stimulation, and in some vessels by the release of cyclooxygenase products. This vasoconstriction may be modulated by the endothelium through the release of NO. Potent vasoconstriction is also observed with E(2)-isoprostanes. Experimental and clinical data suggest a role for F(2)-isoprostanes in atherogenesis. These compounds can be detected in free forms in biological fluids as well as esterified in low-density lipoproteins or cell membranes. Their quantification represents a reliable marker of lipid peroxidation. Elevated levels of F(2)-isoprostanes in biological fluids in pathological conditions including atherosclerosis, ischaemia-reperfusion injury, and inflammatory vascular diseases, suggest a relationship between lipid peroxidation and such diseases. F(2)-isoprostanes are currently being investigated as non-invasive quantitative markers to monitor the response to anti-oxidant treatment. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316945     DOI: 10.1159/000051036

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  16 in total

1.  Greater γ-tocopherol status during acute smoking abstinence with nicotine replacement therapy improved vascular endothelial function by decreasing 8-iso-15(S)-prostaglandin F2α.

Authors:  Eunice Mah; Ruisong Pei; Yi Guo; Christopher Masterjohn; Kevin D Ballard; Beth A Taylor; Alan W Taylor; Maret G Traber; Jeff S Volek; Richard S Bruno
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

Review 2.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

3.  Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.

Authors:  Federico Manuel Daray; Julia Renata Colombo; Julián Rodríguez Kibrik; Andrea Emilse Errasti; Facundo Germán Pelorosso; Wanda Nowak; Jean-Luc Cracowski; Rodolfo Pedro Rothlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08       Impact factor: 3.000

4.  Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

Authors:  Ghainsom D Kom; Edzard Schwedhelm; Renke Maas; Lydia Schneider; Ralf Benndorf; Rainer H Böger
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

Review 5.  A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation.

Authors:  Christopher N Banks; Pamela J Lein
Journal:  Neurotoxicology       Date:  2012-02-10       Impact factor: 4.294

6.  Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men.

Authors:  F Giugliano; K Esposito; C Di Palo; M Ciotola; G Giugliano; R Marfella; M D'Armiento; D Giugliano
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

7.  Correlations of cardiac function with inflammation, oxidative stress and anemia in patients with uremia.

Authors:  Heping Zhang; Lei Fan; Huawei Liao; Lirong Tu; Jie Zhang; Dan Xu; Jiangchao Feng
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

8.  15-F-isoprostane and 5-F-isoprostane are not triggers of myocardial preconditioning.

Authors:  Claire Arnaud; Jean-Luc Cracowski; Ahmed Hakim; Thierry Durand; Alexandre Guy; Diane Godin-Ribuot; Germain Bessard; Christophe Ribuot
Journal:  Clin Exp Pharmacol Physiol       Date:  2005 May-Jun       Impact factor: 2.557

9.  Association of oxidative stress, iron, and centralized fat mass in healthy postmenopausal women.

Authors:  Betsy L Crist; D Lee Alekel; Laura M Ritland; Laura N Hanson; Ulrike Genschel; Manju B Reddy
Journal:  J Womens Health (Larchmt)       Date:  2009-06       Impact factor: 2.681

Review 10.  Novel therapeutic strategies for traumatic brain injury: acute antioxidant reinforcement.

Authors:  Rodrigo Fernández-Gajardo; José Manuel Matamala; Rodrigo Carrasco; Rodrigo Gutiérrez; Rómulo Melo; Ramón Rodrigo
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.